Evidence map›Paper›PMID 31966773›Full record

ArticleInternational journal of clinical and experimental pathology2017

Serum

Gang Wang, Bo Yang, Liangliang Wu, Ting Jin, Qiyan Wu, Lijun Zhang, Lingxiong Wang, Chunxi Liu, Tianyi Liu, Shunchang Jiao

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Gang WangDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Bo YangDivision of Internal Medicine, Department of Oncology, Chinese PLA General Hospital Beijing, China.
Liangliang WuDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Ting JinDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Qiyan WuDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Lijun ZhangDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Lingxiong WangDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Chunxi LiuDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Tianyi LiuDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Shunchang JiaoDivision of Internal Medicine, Laboratory of Oncology, Chinese PLA General Hospital Beijing, China.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer (GC) is one of the most common digestive malignancies worldwide. N-myc downstream-regulated gene 2 (

methodsSerum

resultsthe serum

conclusionThe expression of

Indexed as

diagnosisgastric cancerNDRG2

Identifiers

PMID31966773
PMCPMC6965403
OpenAlexW3026578124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.